Here are five things to know:
1. Per the agreement, RTI Surgical will pay $150 million at closing plus potential future milestone payments. Of the $150 million, $100 million will be paid in cash and the other in share buyouts.
2. RTI Surgical is acquiring 10,729,614 outstanding Paradigm Spine shares for roughly $50 million. The deal is expected to be finalized in the first quarter of 2019.
3. Both companies’ board of directors have approved the acquisition. Additionally, RTI Surgical shareholders and Paradigm Spine equity holders have expressed support of the deal.
4. Paradigm Spine is known for its coflex Interlaminar Stabilization device, a minimally invasive motion preserving implant. The device is backed by 12 years of clinical data.
5. RTI Surgical will fund the $100 million cash closing with new, fully-committed debt financing, which will be provided by Ares Capital Corp.
More articles on devices and implants:
3 things to know about Maxx Medical
Device companies continue to pursue value-based partnerships
OrthoPediatrics reports $15.8M in Q3 revenue: 4 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
